LiPo Batteries for Medical Devices: Safety, Runtime and Qualification
Choose lithium polymer batteries for portable and wearable medical devices using a clear evidence chain: cell safety, pack protection, usable energy, device verification and supplier traceability.
September 21, 2026Green Battery Engineering TeamAbout 12 min read
A medical device battery has to support a defined task for a defined time, including the period needed to warn the user before power is lost. A cell that fits the enclosure and has a large mAh rating can still fail this requirement when an aged battery encounters a radio burst, a pump start or a low-temperature operating condition.
This guide covers rechargeable lithium-ion polymer pouch batteries in external portable and patient-worn equipment. Implantable devices need a separate qualification strategy. The discussion combines official public guidance, a documented device example and explicitly identified calculations; it does not report Green Battery laboratory or clinical testing.
1. What should “medical-grade” mean in a battery specification?
Translate the label into verifiable requirements. Specify the cell model and revision, permitted charge and discharge conditions, pack protection, essential device functions, operating environment and supporting records. Neither pouch construction nor the phrase “medical-grade” establishes a predictable, harmless failure mode. Pouch cells can swell, leak, overheat or ignite if faults or abuse defeat the design safeguards.
Separate three levels of evidence. Cell testing addresses a particular cell design; a pack adds protection electronics, wiring, connectors and assembly; the finished device adds charging, enclosure, software, user interaction and patient exposure. A report at one level is useful evidence for the next level, but does not automatically demonstrate the next level’s safety or market authorization.
Conceptual engineering diagram: evidence must connect the specified cell and pack to the finished device. This is an explanatory illustration, not a test result or certification map for a particular product.
2. Start with the consequences of power loss
Define what happens if the supply voltage collapses, protection opens, the charger fails or the reported state of charge is wrong. A monitor may lose a measurement or an alarm; a treatment device may interrupt delivery. These consequences determine which functions must continue, what warning or backup is needed, and how the device reaches its defined safe state. provides the medical-device risk-management framework; the acceptable risk criteria and controls remain device-specific.
Build a use profile before selecting a cell: sensing and sleep periods, wireless retries, screen brightness, actuator pulses, charging while in use, time between charges, storage duration and intended replacement interval. Include the accessible charger, adapter and accessories. A patient-worn enclosure also changes heat dissipation and mechanical loading. The result should be measurable design inputs, not a list of battery marketing attributes.
3. Keep battery safety, transport and device compliance distinct
Battery safety: IEC 62133-2 concerns portable sealed rechargeable lithium cells and batteries under intended use and reasonably foreseeable misuse. Check the exact model, cell-versus-battery scope, standard edition and amendments, construction and report identity. A matching nominal voltage or similar capacity is insufficient evidence that another model is covered.
Transport: UN 38.3 concerns transport design testing, not clinical performance. PHMSA’s test-summary guidance explains the supporting summary. Obtain the applicable cell and assembled-battery documentation, and match the model and report number. Shipping classification, packaging and documentation still depend on the shipment; a generic “UN38.3 certificate” is not a substitute for that assessment.
Finished equipment: determine the applicable medical electrical equipment standards, including relevant IEC 60601 requirements and device-specific standards. IEC 60601-1-11 addresses home healthcare equipment. Home-use suitability also depends on foreseeable users and environments, not simply on replacing a mains supply with a battery. Confirm editions and regional acceptance for the target submission instead of treating every referenced standard as universally mandatory.
Quality management: ISO 13485:2016 concerns the organization’s quality system. A supplier certificate needs a relevant scope, site and validity, and is not a battery performance test or finished-device authorization. Supplier controls should reflect the manufacturer’s quality system and risk assessment; do not assume every cell supplier must hold an identical certificate.
4. Calculate usable runtime before comparing mAh
Start with energy at the relevant electrical boundary. Nominal energy is approximately Vnom × Ah; verified output energy is the integral of voltage × current over the discharge. The usable result depends on the actual load, temperature, cutoff and battery condition. When comparing different voltages or regulated outputs, capacity in mAh alone is misleading.
Illustrative calculation, not a product test: assume a 3.7 V, 500 mAh cell, 80% remaining energy capability at the chosen aging point, a 90% usable fraction for the specified temperature and cutoff, and 90% conversion efficiency. These independent planning assumptions give 1.85 × 0.80 × 0.90 × 0.90 = 1.1988 Wh at the device side. After allocating a 0.12 Wh device-side warning reserve, 1.0788 Wh remains for normal operation. At a constant 0.18 W device-side load, the estimate is 5.99 hours, approximately 6.0 hours.
Calculated planning example only. The 80%, 90%, 90%, 0.12 Wh and 0.18 W inputs are assumptions, not measured performance or universal design margins. No discharge curve is inferred.
Replace each assumed factor with measured energy for the intended duty cycle. Do not subtract the same cutoff loss twice or apply a capacity-aging factor again when the measured energy already includes aging. Reserve must cover the required warning and response period under the worst justified load, including the energy used by alarms or communications themselves.
5. Check pulse voltage and thermal behavior
Average power does not capture startup and radio peaks. Record voltage at both the battery terminals and device input while applying the actual pulse magnitude, duration, interval and repetition. Include low state of charge, aged samples and intended temperature limits. A protection trip or converter undervoltage shutdown can stop the device while substantial chemical capacity remains.
As a first-order calculation, a 1.0 A current step through 0.15 Ω of total series resistance produces about 0.15 V of resistive drop. This assumed example includes the cell, protection path, contacts and wiring. It excludes slower polarization and is not a measured DCIR value. A pulse-resistance result needs defined SOC, temperature, rest time, sampling instants and ΔI; AC impedance at a stated frequency cannot be substituted without justification.
Protection, charge control and state-of-charge estimation have different jobs. Verify overcharge, overdischarge, overcurrent and temperature responses, including sensor faults and the device’s response to a disconnected pack. Measure cell and enclosure contact temperatures in the assembled configuration. I²R is a useful approximation for one heat contribution, not a complete thermal model or proof of acceptable patient-contact temperature.
6. A documented example: SEM Scanner Model 200
An FDA public De Novo summary, DEN170021, page 5, identifies the SEM Scanner Model 200, a handheld professional-use device. Its specification lists a rechargeable lithium-ion polymer battery, at least 3 hours of continuous operation, inductive charging and a temperature-detection function that stops charging above its threshold. The stated device environment is 15–35°C and 5–90% relative humidity, non-condensing.
This is a documented device specification, not a published raw battery test dataset. The cited table does not disclose the cell model, Ah capacity, load waveform, aging state, battery sample count or numerical charging threshold. Therefore it cannot establish a battery’s energy density, cycle life or runtime in another design. It is also not evidence that a patient-worn device, an implant or a different supplier’s cell meets the same requirements.
The useful engineering lesson is the grouping of runtime, charging, thermal control and enclosure in a device-level specification. Use that structure to organize your own evidence, then measure the values for your product.
7. Build a test plan that can be reproduced
Energy and runtime: identify model, revision, lot and sample count; record charge CC/CV limits, termination current, rests, temperature, discharge profile and cutoff. Log Ah, Wh, voltage and current until the defined device endpoint, rather than reporting only the cell’s nominal capacity.
Dynamic load: document pulse amplitude, duration, interval, SOC, temperature and sample age. Log voltage minima, reset events, communication failures and protection operation. Repeat the critical combinations identified by risk analysis and explain the sample-size rationale.
Thermal and charging: test within the approved cell limits using the intended charger and enclosure. Record ambient, cell-surface and relevant enclosure temperatures, sensor positions, airflow, mounting and stop criteria. Include use while charging only if intended, and verify applicable fault responses with qualified facilities.
Aging and storage: specify cycle depth, charge/discharge rates, temperature, rests and measurement intervals. Track energy, pulse resistance, swelling and abnormal events as well as capacity. Separate calendar storage from cycle aging; a claim of 500 cycles is incomplete without its retention threshold and protocol. Storage loss must distinguish cell self-discharge from protection, gauge and device standby consumption.
Warnings and continuity: measure remaining operating time after the low-battery indication under representative and worst justified loads. Check alarm visibility or audibility, user response, backup changeover if provided, data retention and safe shutdown. FDA home-use guidance, section VII.E, discusses operating time, recharging, replacement and advance low-battery notification.
Report both successes and failures. Retain raw time-series files, calibration information, deviations and retest reasons. Pass/fail limits should be agreed before the test; unexplained resets, excess heating or swelling should not disappear into an average.
8. Engineer the enclosure and patient interface
A pouch cell’s thin packaging does not make it a freely bendable structural element. Control stack tolerances, expansion space, tab strain relief, edge pressure and puncture hazards using the supplier’s mechanical limits. Assess drops, wear, sweat ingress and connector handling at device level. Cleaning compatibility does not imply suitability for steam, radiation or other sterilization processes.
Assess the materials that actually contact the patient, directly or indirectly, including enclosure, adhesive and any relevant exposure pathway. FDA’s biocompatibility overview explains this contact-based approach. An enclosed battery is not automatically required to undergo the same biological tests as a skin adhesive, and a biocompatible outer enclosure does not eliminate battery fault hazards.
9. Make supplier changes and traceability actionable
Request a controlled cell specification, mechanical drawing, protection and connector configuration, applicable reports and transport summary, manufacturing site and lot identification, inspection criteria and agreed change-notification process. Connect the device’s serial or batch record to the installed battery lot at the level justified by the quality system. Confirm report identity and model coverage, rather than relying on a logo in a catalogue.
A change in cell design, chemistry, materials, manufacturing site, protection thresholds or pack assembly needs a documented impact assessment. Decide what verification or regulatory action is necessary for that change; not every small change demands an identical full retest, and none should be accepted solely because the replacement has the same mAh rating. Define how complaints, field failures and corrective actions reach the responsible parties.
10. Questions to resolve before design freeze
Is a 3.7 V pouch battery automatically suitable for a wearable medical device?
No. Check full-charge voltage, allowable current, device cutoff, charger compatibility, mechanical loading and the intended patient interface. The appropriate capacity and voltage depend on the device’s task and verified power profile.
Does IEC 62133-2 or UN 38.3 establish medical-device approval?
No. They address different battery and transport questions. Finished-device safety, essential performance, biological evaluation where applicable and the target market’s authorization route require their own evidence.
Can a protection board guarantee that no patient hazard occurs?
No. Protection can reduce specified electrical risks, but cannot by itself guarantee thermal, mechanical, software, enclosure or treatment continuity performance. Validate the complete fault response and the risks remaining after the controls.
11. Turn the assessment into a purchasing specification
A useful request for quotation states the load waveform, normal operating time and warning reserve, temperature and aging conditions, size and expansion allowance, charging arrangement, replacement strategy, target markets and required documents. Attach measurable acceptance criteria and a validation schedule before comparing price or nominal capacity.
Use the lithium polymer battery range for an initial form-factor discussion, and send the device power profile for model-specific evaluation. The decision to adopt a battery should follow the measured device evidence and agreed supplier controls. An attractive specification becomes useful only when it can be traced to the exact battery and the device conditions in which it must work.
Procurement & Engineering Solutions
Related Battery Categories & Manufacturing Capacities
Looking to evaluate specifications or request custom engineering samples? Explore our verified product lines below:
